Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 15, 2007
Intraluminal thread model of focal stroke in the non-human primateThomas Freret, Valentine Bouet, Jérôme Toutain, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 15, 2008
Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in ratsElise Esneault, Emilie Pacary, Dauphou Eddi, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 18, 2024
Deformation-based morphometry: a sensitive imaging approach to detect radiation-induced brain injury?Carole Brunaud, Samuel Valable, Gwenn Ropars, et al.Bioorganic & Medicinal Chemistry|June 23, 2009
Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in miceInmaculada Berenguer, Noureddine El Aouad, Sebastián Andujar, et al.British Journal of Pharmacology|December 28, 2019
Donecopride, a Swiss army knife with potential against Alzheimer's diseaseChristophe Rochais, Cédric Lecoutey, Katia Hamidouche, et al.British Journal of Clinical Pharmacology|August 8, 2022
Association between road traffic accidents and drugs belonging to the antiseizure medications class: A pharmacovigilance analysis in VigiBaseBasile Chrétien, Sophie Nguyen, Charles Dolladille, et al.Molecules (Basel, Switzerland)|August 3, 2019
Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's DiseaseFrançois-Xavier Toublet, Cédric Lecoutey, Julien Lalut, et al.European Journal of Medicinal Chemistry|December 14, 2020
Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT<sub>6</sub> receptor antagonist with therapeutic interest in Alzheimer's diseaseFrançois-Xavier Toublet, Julien Lalut, Bérénice Hatat, et al.Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatmentCédric Lecoutey, Damien Hedou, Thomas Freret, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 30, 2012
Vezatin is essential for dendritic spine morphogenesis and functional synaptic maturationLydia Danglot, Thomas Freret, Nicolas Le Roux, et al.Pageof 9